EVH (Evolent Health) Cash Flow for Dividends: $-7 Mil (TTM As of Mar. 2026)


EVH Evolent Health Inc EVH
60 GF Score
Price $5.03
GF Value $11.05
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Evolent Health Cash Flow for Dividends?

Evolent Health EVH +4.79% 60 Cash Flow for Dividends is $-7 Mil as of Mar. 2026. GuruFocus rates EVH with a GF Score™ of 60/100 and a GF Value™ of $11.05 (Possible Value Trap). The stock has 6 warning signs investors should review.

Evolent Health's cash flow for dividends for the three months ended in Mar. 2026 was $0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Mar. 2026 was $-7 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Evolent Health's quarterly payment of dividends declined from Sep. 2025 ($-2 Mil) to Dec. 2025 ($0 Mil) but then stayed the same from Dec. 2025 ($0 Mil) to Mar. 2026 ($0 Mil).

Evolent Health's annual payment of dividends increased from Dec. 2023 ($-19 Mil) to Dec. 2024 ($-20 Mil) but then declined from Dec. 2024 ($-20 Mil) to Dec. 2025 ($-11 Mil).

Evolent Health Cash Flow for Dividends Related Terms

Evolent Health Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for Evolent Health's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Evolent Health Cash Flow for Dividends Chart

Evolent Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.30 -14.88 -18.79 -20.09 -11.13

Evolent Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.58 -4.62 -1.93 0.00 0.00
EVH
60GF Score
Evolent Health Inc EVH
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Evolent Health Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of $-7 Mil mean?
Evolent Health (EVH) has a Cash Flow for Dividends of $-7 Mil as of Mar. 2026. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Evolent Health and its competitors.
Is Evolent Health's Cash Flow for Dividends too high?
Evolent Health's current Cash Flow for Dividends is $-7 Mil. Overall, Evolent Health has a GF Score™ of 60/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Evolent Health's Cash Flow for Dividends compare to NRC and CTEV?
Evolent Health's Cash Flow for Dividends of $-7 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Healthcare Providers & Services company?
A good Cash Flow for Dividends depends on the Healthcare Providers & Services industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Evolent Health and its competitors. Evolent Health's current Cash Flow for Dividends is $-7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evolent Health stock overvalued right now?
Based on GuruFocus' analysis, Evolent Health (EVH) is currently considered Possible Value Trap. The stock's GF Value™ is $11.05, compared to a current price of $5.03 — trading 54.5% below its estimated fair value. The current Cash Flow for Dividends is $-7 Mil. Evolent Health's overall GF Score™ is 60/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Evolent Health (EVH), the current Cash Flow for Dividends is $-7 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Evolent Health (EVH) Overvalued in 2026?

Based on GuruFocus' analysis, Evolent Health stock appears to be undervalued. The current stock price of $5.03 is trading 54.5% below its estimated GF Value™ of $11.05. GuruFocus considers Evolent Health to be Possible Value Trap.

Key valuation signals for EVH:

  • Cash Flow for Dividends: $-7 Mil
  • GF Value™: $11.05 vs. price of $5.03 (54.5% below fair value)
  • GF Score™: 60/100 with 6 warning signs

No single metric tells the full story. See the EVH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Evolent Health Business Description

Other Exchanges 9EH:Germany
Address 1812 North Moore Street, Suite 1705, Arlington, VA, USA, 22209
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The solutions provided by the company includes: Oncology, Cardiology, Musculoskeletal, Administrative Services, Advanced Illness, Genetic Testing, Physical Medicine, Radiology, and Surgical Management.
60GF Score

Get the complete analysis for EVH

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.03
Price
$11.05
GF Value